About 1 result found for searched term "Cosibelimab" (0.488 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24992 | Cosibelimab | PD-1/PD-L1 |
| CK-301; TG-1501 | ||
| Cosibelimab (CK-301; TG-1501) is a high-affinity, fully human PD-L1-blocking monoclonal antibody that binds PD-L1 and blocks its interaction with PD-1. Cosibelimab has a functional Fc domain and is capable of inducing ADCC and complement-dependent cytotoxicity (CDC)-mediated killing of PD-L1+ cell lines, including lymphoma cells. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
